Abstract：Objective:To investigate the effects of comprehensive behavioral interventions on the progression of patients with chronic obstructive pulmonary disease (COPD). Methods: 106 cases of COPD in our hospital from March 2015 to May 2017 were selected. If they received comprehensive behavioral intervention, they were divided into observation group and control group. The control group received conventional treatment only, while the observation group received comprehensive behavioral intervention on the basis of conventional treatment. The patients of two groups were received respiratory function assessment after 6 months, and their quality of life and the number of acute attacks of COPD were evaluated. Results: After 6 months' intervention, the FEV1, FEV1% and the number of acute attacks in the observation group were significantly better than those in the control group, the difference was statistically significant (P<0.05). In the observation group, the social psychological influence, activity, respiratory symptoms and total scores in the SGRQ assessment scale were significantly lower than those in the control group at 6 months. The difference was statistically significant (P<0.05). Conclusion: The implementation of comprehensive behavioral intervention in patients with COPD can effectively improve lung function and quality of life of patients with chronic obstructive pulmonary disease, help to delay the progression of patients' condition, and has a very positive effect on the control of disease progression. It is recommended for clinical application.
[1] 刘梅,滕敬华.阶段性干预法对慢性阻塞性肺疾病患者预后的影响研究[J].现代中西医结合杂志,2017,26(7):785~788.
[2] 徐艳,欧勤芳.基于人本化理念的认知行为干预在老年慢性阻塞性肺疾病病人中的应用[J].护理研究,2017,31(5):551~554.
[3] 刘蕾,杨晓霞,曾婕,等.延续护理对慢性阻塞性肺疾病出院患者的干预效果[J].中国老年学杂志,2014,34(12):3333~3335.
[4] Sorensen S S, Weinreich U M, Ehlers L. Rationale and development of a patient-tailored complex intervention of case management for patients suffering from chronic obstructive pulmonary disease[J]. Home Health Care Serv Q,2017, 36(3~4): 178~195.
[5] Gregoriano C, Dieterle T, Durr S, et al. Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial[J]. JMIR Res Protoc,2017, 6(10): e204.
[6] 张春玲,刘银芳,张伟华,等.干预管理对慢性阻塞性肺疾病患者生存质量的影响[J].中华健康管理学杂志,2014,8(1):48~50.
[7] 阙利洁.认知行为干预对慢性阻塞性肺疾病患者治疗依从性和生活质量的影响[J].中西医结合护理(中英文),2017,3(2):124~127.
[8] 陈淑娴,徐健翔,梁敏娇,等.布地奈德在慢性阻塞性肺疾病治疗与干预效果分析[J].中国生化药物杂志,2017,37(8):331~332.
[9] Tashkin D P, Bateman E D, Jones P, et al. Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses[J]. Respir Med,2016, 120: 91~100.
[10] 李娜,初雪云,修麓璐,等.慢性阻塞性肺疾病患者系统化自我效能干预的效果[J].中国医药导报,2015,12(13):156~160.
[11] 陈平.慢性阻塞性肺疾病气道炎症和气道重塑的中医药干预研究进展[J].现代中西医结合杂志,2016,25(13):1474~1476.
[12] 张开宇,吴同利,刘欣欣,等.六味补气方联合常规治疗对慢性阻塞性肺疾病急性加重期的疗效研究[J].中国中医急症,2016,25(11):2115~2117.
2018, Vol. 24 
冀公网安备13080202000677号